CLINICAL_TRIALS ClinicalTrials.gov record update

Phase 1 Clinical Trial of ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT05542407
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:28:32.524175+00:00
Published At: 2026-01-29T00:00:00+00:00
Record Updated At: 2026-01-29
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Endometrial Cancer", "Metastasis", "Endometrioid Endometrial Cancer", "Carcinosarcoma", "Serous Adenocarcinoma of Endometrium (Diagnosis)", "Clear Cell Endometrial Carcinoma", "Endometrial Endometrioid Adenocarcinoma", "Endometrial Mixed Cell Adenocarcinoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2026-01-29"
protocolSection.identificationModule.nctId: "NCT05542407"
protocolSection.identificationModule.officialTitle: "Phase 1 Clinical Trial of ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer"
protocolSection.statusModule.overallStatus: "RECRUITING"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.